Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05103202 · ClinicalTrials.gov registry record
Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
A clinical trial of Cervical Dystonia and Spasticity, Muscle, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 105
- Enrollment target
- 1
- Study location
NCT05103202 is a study of Cervical Dystonia and Spasticity, Muscle that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 105 participants, above the 80-participant average among 15 other Cervical Dystonia trials with a reported enrollment target (31% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05103202, a study of Cervical Dystonia and Spasticity, Muscle, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
Our hypothesis is that botulinum toxin injections (with onabotulinum toxin, incobotulinum toxin, and abobotulinum toxin) given at 10-week or shorter intervals for the indication of treatment of muscle spasms associated with neurological disorders are associated with equal safety and effectiveness as those given at 12-week or longer intervals. We also hypothesize that for those patients who would prefer a shorter inter-injection interval, but for whom their insurance carrier has prevented this, have worse health-related quality of life compared to patients who receive injections at a 10-week or shorter interval. We aim to investigate this hypothesis by collecting demographic and injection data and patient survey responses.
Conditions Studied
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2021-11-04 |
| Est. Completion | 2022-06-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05103202
The ClinicalTrials.gov registry entry for NCT05103202 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 80-participant average among 15 other Cervical Dystonia trials with a reported enrollment target (31% higher). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Cervical Dystonia appearing as the primary indexed condition, and to 0 interventions.
NCT05103202 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05103202 about?
NCT05103202 is a clinical study titled "Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin". Our hypothesis is that botulinum toxin injections (with onabotulinum toxin, incobotulinum toxin, and abobotulinum toxin) given at 10-week or shorter intervals for the indication of treatment of muscle spasms associated with neurological disorders are associated with equal safety and effectiveness as...
What is the current status of trial NCT05103202?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2021-11-04. Estimated completion is 2022-06-14.
What conditions does trial NCT05103202 study?
This clinical trial studies the following conditions: Cervical Dystonia, Spasticity, Muscle, Blepharospasm, Hemifacial Spasm, Limb Dystonia.
Who is sponsoring clinical trial NCT05103202?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05103202 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Dystonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
RECRUITING · Phase 2
-
Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia
RECRUITING · Phase 2
-
Effect of Vibro-tactile Stimulation Intensity on Head Posture in Cervical Dystonia
RECRUITING · NA
-
Zinc as an Adjunctive Therapy for Cervical Dystonia
RECRUITING · Phase 2
-
Deep Brain Stimulation to Treat Cervical Dystonia
COMPLETED · Phase 1
-
Safety and Tolerability of Perampanel in Cervical Dystonia
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.